首页 | 本学科首页   官方微博 | 高级检索  
检索        

穴位贴敷鼻敏通能量贴治疗过敏性鼻炎的疗效观察
引用本文:汤小荣,李知行,旷徐,及维明,李艺彤,王琳,许能贵,李宛谘,杨忠华.穴位贴敷鼻敏通能量贴治疗过敏性鼻炎的疗效观察[J].广州中医药大学学报,2021,38(3):524-530.
作者姓名:汤小荣  李知行  旷徐  及维明  李艺彤  王琳  许能贵  李宛谘  杨忠华
作者单位:广州中医药大学,广东广州 510006;广州中医药大学第四临床医学院,广东深圳 518033;南方医科大学附属深圳妇幼保健院,广东深圳 518028;香港世霸潜能科研有限公司,香港 999077
基金项目:国家自然科学基金青年项目(编号:81904297);广东省中医针灸重点实验室开放运行项目(编号:2017B030314143);广州中医药大学科研创新团队建设项目(编号:2016KYTD03);广州中医药大学青年英才培养工程(编号:QNYC20190106)。
摘    要:目的]观察穴位贴敷鼻敏通能量贴治疗过敏性鼻炎的临床疗效.方法]将100例过敏性鼻炎患者随机分为观察组和对照组,每组各50例.观察组给予穴位贴敷鼻敏通能量贴治疗,选取迎香穴、神阙穴,每天1次,每次持续贴敷8 h,每周治疗5次,共治疗4周;对照组给予氯雷他定片口服治疗,每天1次,每次1片,每周治疗5次,连续服用4周.观...

关 键 词:过敏性鼻炎  穴位贴敷  鼻敏通能量贴  生活质量  疗效观察

Clinical Observation on Acupoint Application with Bimintong-Energy Patch for Treatment of Allergic Rhinitis
TANG Xiao-Rong,LI Zhi-Xing,KUANG Xu,JI Wei-Ming,LI Yi-Tong,WANG Lin,XU Neng-Gui,LI Wan-Zi,YANG Zhong-Hua.Clinical Observation on Acupoint Application with Bimintong-Energy Patch for Treatment of Allergic Rhinitis[J].Journal of Guangzhou University of Traditional Chinese Medicine,2021,38(3):524-530.
Authors:TANG Xiao-Rong  LI Zhi-Xing  KUANG Xu  JI Wei-Ming  LI Yi-Tong  WANG Lin  XU Neng-Gui  LI Wan-Zi  YANG Zhong-Hua
Institution:(Guangzhou University of Chinese Medicine,Guangzhou 510006 Guangdong,China;The Fourth Clinical Medical School of Guangzhou University of Chinese Medicine,Shenzhen 518033 Guangdong,China;Shenzhen Manternity and Child Healthcare Hospital of Southern Medical University,Shenzhen 518028 Guangdong,China;Xyber Force Technology Co.,Ltd.,Hong Kong 999077,China)
Abstract:Objective To observe the clinical efficacy of acupoint application with Bimintong-Energy Patch for allergic rhinitis.Methods A total of 100 cases of patients with allergic rhinitis were randomly divided into observation group and control group,50 cases in each group.The observation group received acupoint application with Bimintong-Energy Patch at Yingxiang(LI20)and Shenque(CV8)points,once a day,8 hours per time,5 times per week,the treatment lasting 4 weeks.The control group received loratadine tablets orally once a day,one tablet per time,5 times a week,the treatment lasting 4 weeks.The changes in visual analogue scale(VAS)nasal symptom scores,VAS non-nasal symptom scores,total nasal symptom scale(TNSS)scores,total nonnasal symptoms score(TNNSS),rhino-conjunctivitis quality of life questionnaire(RQLQ)score and serum total immune globulin(IgE)and eosnophils count in the two groups were observed before and after treatment,and 3 months after treatment,and the safety in the two groups was evaluated.Results(1)After one,2,3,4 weeks of treatment and during follow-up after 3 months of treatment,the VAS nasal symptom scores and VAS non-nasal symptom scores in the two groups were improved,the differences being significant in comparison to those before treatment(P<0.05).During follow-up after 3 months of treatment,the VAS nasal symptom scores and VAS nonnasal symptom scores in the observation group were improved,the differences being significant in comparison to those in the control group(P<0.05),but after one,2,3,4 weeks of treatment,there was no significant difference in VAS nasal symptom scores between the two groups(P>0.05)(.2)After 2,4 weeks of treatment,the TNSS scores in the two groups were improved,the differences being significant in comparison to those before treatment(P<0.05).After 2,4 weeks of treatment,there was no significant difference in TNSS scores between the two groups(P>0.05).(3)After 2,4 weeks of treatment,the TNNSS scores in the observation group were improved,the differences being significant in comparison to those before treatment(P<0.05),and the TNNSS scores in the control group were improved,but the differences being insignificant in comparison to those before treatment(P>0.05).After 2,4 weeks of treatment,the TNNSS scores in the observation group were improved,the differences being significant in comparison to those in the control group during the same period(P<0.05).(4)After 2,4 weeks of treatment,the RQLQ scores in the two groups were improved,the differences being significant in comparison to those before treatment(P<0.05).After 2,4 weeks of treatment,the RQLQ scores in the observation group were improved,but the differences being insignificant in comparison to those in the control group during the same period(P>0.05).(5)After 4 weeks of treatment,the total IgE and EOS levels in the two groups were improved,but the differences being insignificant in comparison to those before treatment(P<0.05),and the total IgE and EOS levels in the observation group were improved,but the differences being insignificant in comparison to those in the control group during the same period(P>0.05).(6)All the patients completed the treatment course.There was no significant difference in safety between the two groups(P>0.05).Conclusion Acupoint application with Bimintong-Energy Patch is effective for improving the clinical symptoms of the allergic rhinitis patients,and promoting quality of life of the patients.
Keywords:allergic rhinitis  acupoint application  Bimintong-Energy Patch  quality of life  curative efficacy observation
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号